IMIDomics

50 posts

IMIDomics banner
IMIDomics

IMIDomics

@IMIDomics

The IMID drug discovery company. Committed to improving the lives of patients with immune-mediated inflammatory diseases.

Barcelona and San Francisco CA Katılım Aralık 2019
68 Takip Edilen108 Takipçiler
IMIDomics
IMIDomics@IMIDomics·
What's the future of #autoimmunedisease treatment? Our partnership with @FormationBio aims to answer that question! Check out our latest video featuring Fred Craves discussing the collaboration & its potential impact on #autoimmunedisease treatment #drugdiscovery #PrecisionMedicine #Biotech
Formation Bio@formationbio

@IMIDomics discovered the initial science, and now @formationbio is taking it forward to clinical development. Today we announced our license of IMIDomics' first-in-class, Phase-1 ready anti-CD226 antibody targeting Ulcerative Colitis. Go behind the scenes with both teams here.

English
0
4
9
521
IMIDomics
IMIDomics@IMIDomics·
We are thrilled to announce that respected Matthias Evers, Ph. D., will join the IMIDomics Board of Directors effective October 1, 2024. Dr. Evers' significant expertise and insights will be critical as we advance our mission of delivering breakthrough medicines for IMIDs.
English
0
0
0
110
IMIDomics
IMIDomics@IMIDomics·
We are honored and excited to announce a strategic equity investment from @UCB_News Together, we look forward to advancing novel solutions that address the unmet needs of patients suffering from #IMIDs. Read more here: ucb.com/stories-media/…
UCB News@ucb_news

Pleased to announce a strategic investment in IMIDomics.🎉 Their innovative approach in developing novel medicines aligns with our mission to improve patient lives. #UCB #IMIDomics #Innovation.

English
0
0
5
186
IMIDomics retweetledi
UCB News
UCB News@ucb_news·
Pleased to announce a strategic investment in IMIDomics.🎉 Their innovative approach in developing novel medicines aligns with our mission to improve patient lives. #UCB #IMIDomics #Innovation.
English
1
2
5
647
IMIDomics
IMIDomics@IMIDomics·
“Today, we announced the expansion of our strategic collaboration with @bmsnews to accelerate research and development aimed at understanding and uncovering mechanisms driving Sjögren's disease and atopic dermatitis.” businesswire.com/news/home/2023…
English
0
0
1
115
IMIDomics
IMIDomics@IMIDomics·
Thrilled to announce Dr. Eric Perakslis as our new Senior VP & CTO, bringing stellar expertise in pharma R&D. Welcoming Dr. Ramon Felciano as a strategic advisor in biomedical AI and data science. Exciting times ahead shaping the future of IMIDomics! businesswire.com/news/home/2023…
English
0
1
1
127
IMIDomics
IMIDomics@IMIDomics·
Congratulations to Dr. Sara Marsal on receiving the Trifermed Award for Social Impact in Healthcare! awards.trifermed.com/?_gl=1%2A8f056… Dr. Marsal's remarkable dedication to the field of rheumatology and her outstanding contributions to the understanding and treatment of IMIDs.
English
0
2
5
292
IMIDomics
IMIDomics@IMIDomics·
Today, we announced a strategic agreement with @WuXiBiologics to accelerate the development and manufacturing of IMIDomics IMB1001, a highly promising humanized antibody targeting CD226, a breakthrough target for treating #IMIDs. Read more: businesswire.com/news/home/2023…
English
0
1
4
198
IMIDomics
IMIDomics@IMIDomics·
IMIDomics Inc. Secures Exclusive Worldwide Licensing Agreement with TNAX Biopharma Corporation for TNAX101A (IMB1001), A Promising Drug Candidate for Immune-Mediated Inflammatory Diseases businesswire.com/news/home/2023…
English
0
1
5
580
IMIDomics
IMIDomics@IMIDomics·
We’re thrilled to announce the creation of our Immunology Advisory Board. The luminaries will support us refine our Precision Discovery Engine, and moving forward with identifying and pursuing targets for potential new treatments#IMIDs. businesswire.com/news/home/2022…
English
0
2
3
0
IMIDomics
IMIDomics@IMIDomics·
Proud to receive this recognition from the CataloniaBio & HealthTech. It reflects our continuous commitment to IMID patients. en.vhir.org/portal1/news-d…
English
0
1
4
0
IMIDomics
IMIDomics@IMIDomics·
We are thrilled to announce that @Evotec has made a strategic investment in IMIDomics that reflects our shared goal of leveraging data to discover and develop meaningful treatments to improve the health and quality of life of IMID patients. businesswire.com/news/home/2022…
English
0
4
12
0
IMIDomics
IMIDomics@IMIDomics·
We’re thrilled to announce the creation of our Scientific Advisory Board and Business Advisory Board. The esteemed members will support us as we continue our precision discovery efforts to identify new therapies for #IMIDs. More Information: businesswire.com/news/home/2021…
English
0
2
3
0

Keşfet

@FormationBio @ucb_news @bmsnews @UniBarcelona @WuXiBiologics @TwistBioscience @PCB_UB @_inBrain